GB202103975D0 - Treatment of HS - Google Patents
Treatment of HSInfo
- Publication number
- GB202103975D0 GB202103975D0 GBGB2103975.5A GB202103975A GB202103975D0 GB 202103975 D0 GB202103975 D0 GB 202103975D0 GB 202103975 A GB202103975 A GB 202103975A GB 202103975 D0 GB202103975 D0 GB 202103975D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2103975.5A GB202103975D0 (en) | 2021-03-22 | 2021-03-22 | Treatment of HS |
| BR112023019309A BR112023019309A2 (en) | 2021-03-22 | 2022-03-22 | TREATMENT OF HIDRADENITIS SUPpurativa WITH ORISMILASTE |
| US18/551,157 US20250268876A1 (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
| KR1020237035255A KR20230159485A (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa using orismilast |
| CA3212316A CA3212316A1 (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
| PCT/EP2022/057472 WO2022200339A1 (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
| EP22717748.2A EP4313043A1 (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
| MX2023011176A MX2023011176A (en) | 2021-03-22 | 2022-03-22 | TREATMENT OF HIDRADENITIS SUPPURATIVA WITH ORISMILAST. |
| IL306020A IL306020A (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
| JP2023558591A JP2024511141A (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orysmilast |
| AU2022245186A AU2022245186A1 (en) | 2021-03-22 | 2022-03-22 | Treatment of hidradenitis suppurativa with orismilast |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2103975.5A GB202103975D0 (en) | 2021-03-22 | 2021-03-22 | Treatment of HS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202103975D0 true GB202103975D0 (en) | 2021-05-05 |
Family
ID=75689734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2103975.5A Ceased GB202103975D0 (en) | 2021-03-22 | 2021-03-22 | Treatment of HS |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202103975D0 (en) |
-
2021
- 2021-03-22 GB GBGB2103975.5A patent/GB202103975D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202006665D0 (en) | Treatment of ischaemia | |
| GB202016058D0 (en) | Therapeautic treatment | |
| GB202003722D0 (en) | Treatment | |
| GB202103975D0 (en) | Treatment of HS | |
| GB202001353D0 (en) | Treatment of skin conditions | |
| GB202018400D0 (en) | Treatment | |
| GB202101251D0 (en) | Treatment of conditions | |
| GB202002711D0 (en) | Treatment | |
| GB202315695D0 (en) | TReatment of cariomyopathy | |
| GB202212506D0 (en) | Treatment of covid-19 | |
| SMT202400302T1 (en) | Treatment of cholangiopathies with seladelpar | |
| GB202307686D0 (en) | Treatment of conditions | |
| GB202118011D0 (en) | Methods of treatment | |
| GB202118006D0 (en) | Methods of treatment | |
| GB202118007D0 (en) | Methods of treatment | |
| GB202108245D0 (en) | Methods of treatment | |
| GB202108242D0 (en) | Methods of treatment | |
| GB202010319D0 (en) | Treatment of biofilms | |
| GB202005874D0 (en) | Methods of treatment | |
| IL308377A (en) | Methods of treating dermatomyositis | |
| GB202116774D0 (en) | Treatment of pain | |
| GB202110146D0 (en) | Treatment of respiratory conditions | |
| GB202002291D0 (en) | Treatment of corneal vasularisation | |
| GB202102950D0 (en) | Method of treatment | |
| GB202018062D0 (en) | Treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |